The Swedish BioFINDER - Primary Care Study
Launched by SKANE UNIVERSITY HOSPITAL · Nov 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Swedish BioFINDER - Primary Care Study is a clinical trial designed to improve how doctors in primary care settings diagnose mild dementia and cognitive issues, including Alzheimer’s disease and other related conditions. The goal is to help doctors identify these problems earlier and more accurately so that patients can receive the right care and be referred to specialized memory clinics when needed. The study will involve developing new tests using simple blood tests, brain scans, and cognitive assessments that can be easily used in a primary care environment.
To participate in this study, you need to be at least 40 years old and experiencing cognitive symptoms, like memory problems, that concern either you or your doctor. However, if you have already been diagnosed with dementia, have certain health issues, or your cognitive problems are caused by a different condition, you may not be eligible. If you join, you can expect to undergo various tests to assess your cognitive health, and the findings may help improve how cognitive issues are managed in the future. This study is currently recruiting participants of all genders and backgrounds to ensure a diverse group.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The patient seeks medical help because of cognitive symptoms experienced by the patient and/or informant OR The general practitioner suspects a progressive neurodegenerative disorder including, but not limited to, Alzheimer's disease, Lewy body disease, frontotemporal lobar degeneration or subcortical vascular cognitive impairment.
- • 2. The main symptom is usually memory complaints, but could also be executive, visuo-spatial, language, or attention complaints.
- • 3. Age ≥40 years
- • 4. Subjective cognitive decline, mild cognitive impairment or mild dementia
- Exclusion Criteria:
- • 1. Already diagnosed dementia
- • 2. Significant unstable systemic illness or organ failure that makes it difficult to participate.
- • 3. Current significant alcohol or substance misuse.
- • 4. Refusing investigation at the Memory clinic
- • 5. Cognitive impairment with acute onset due to stroke
- • 6. The cognitive impairment can with certainty be explained by another condition or disease such as significant anemia, infection, severe sleep deprivation, psychotic disorder, moderate-severe depression, alcohol abuse etc.
About Skane University Hospital
Skåne University Hospital is a leading academic medical center located in Sweden, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a key player in the Nordic healthcare landscape, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, aiming to improve patient outcomes and foster advancements in medical knowledge. With a multidisciplinary approach, Skåne University Hospital collaborates with various stakeholders, including universities and research institutions, to conduct high-quality clinical trials that address critical health challenges and contribute to the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malmö, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported